Immediate Impact

18 standout
Sub-graph 1 of 7

Citing Papers

A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
2024 Standout
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
2023 Standout
2 intermediate papers

Works of İpek Kaplan Bulut being referenced

Cytomegalovirus Experience in Pediatric Kidney Transplantation in 26 Years’ Time
2020
Outcome results in children with IgA nephropathy: a single center experience
2012

Author Peers

Author Last Decade Papers Cites
İpek Kaplan Bulut 20 15 11 46 37 26 112
Gianluca Vergine 9 4 27 41 28 21 132
Rakesh Kumar 19 12 8 21 12 23 110
Noha Musa 6 10 19 53 47 25 185
Sherif M. El-Desoky 68 10 15 22 38 21 128
Nusret Can Çilesiz 8 7 36 12 24 28 122
John Nichols 16 23 28 20 23 18 192
Stephanie Dufek 71 6 20 24 49 18 185
Mastaneh Moghtaderi 79 13 10 17 18 22 141
Bahriye Atmış 25 7 19 45 13 27 104
Halina Borzęcka 39 25 27 24 57 26 134

All Works

Loading papers...

Rankless by CCL
2026